high sen troponin
Device
Abbott Laboratories
Total Payments
$654,576
Transactions
6
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $654,576 | 6 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $654,576 | 6 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of Cardiovascular Biomarkers in the Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification (REVEAL) TIMI-55 | Abbott Laboratories | $654,576 | 0 |
Top Doctors Receiving Payments for high sen troponin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $654,576 | 6 |
Ad
Manufacturing Companies
- Abbott Laboratories $654,576
Product Information
- Type Device
- Total Payments $654,576
- Total Doctors 0
- Transactions 6
About high sen troponin
high sen troponin is a device associated with $654,576 in payments to 0 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $654,576 was paid across 6 transactions to 0 doctors.
The most common payment nature for high sen troponin is "Unspecified" ($654,576, 100.0% of total).
high sen troponin is associated with 1 research study, including "Evaluation of Cardiovascular Biomarkers in the Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification (REVEAL) TIMI-55" ($654,576).